US.MCK · McKesson Corporation

{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.6,
      "details": {
        "atrPct": 2.338444065871664,
        "turnoverUsdM": 584.5260885,
        "liquidityPoints": 0.6,
        "volatilityPoints": 1
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.MCK",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 839.32,
      "strength_details": {
        "ma_score": 1.5,
        "atr_score": 2,
        "rsi_score": 2.5,
        "macd_score": 1.5,
        "volume_score": 1
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1.1,
      "stop_loss_percent": 4.7,
      "take_profit_price": 924.525,
      "target_multiplier": 1.9,
      "technical_strength": 1.68,
      "take_profit_percent": 5
    },
    "positionPoints": 1.6,
    "stopLossPoints": 2.4,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 4.676888131743328,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 58.3,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 53.3,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 5
  },
  "market": {
    "ma20": 894.009,
    "ma50": 871.4004,
    "close": 880.5,
    "prevClose": 891.23,
    "avgVolume20": 968553,
    "volumeRatio": 0.69,
    "changePercent": -1.2
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 5,
    "details": {
      "ret_5d": -0.0076524925932331955,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 5,
      "vcp_bonus": 0,
      "vol_ratio": 0.6777576397519015,
      "ret_points": 0,
      "vol_points": 0,
      "range_ratio": 1.4024761125140295,
      "volat_points": 2,
      "day_range_pct": 0.030176044293015368,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 3,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 58.3,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 3.6,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 72,
        "contribution": 3.6
      },
      {
        "raw": 8.4,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 42,
        "contribution": 8.4
      },
      {
        "raw": 11,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 73.33,
        "contribution": 11
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 7.4,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 74,
        "contribution": 7.4
      },
      {
        "raw": 16.9,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 56.33,
        "contribution": 16.9
      },
      {
        "raw": 4,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 40,
        "contribution": 4
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "避免",
    "result": 53.3,
    "details": [
      "基本面分析總分: 3.6/5分",
      "資金流分析總分: 8.4/20分",
      "市場環境分析總分: 11/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 7.4/10分",
      "技術信號分析總分: 16.9/30分",
      "情緒分析: 4/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 3.6,
      "資金流": 8.4,
      "市場環境": 11,
      "情緒分析": 4,
      "技術信號": 16.9,
      "風險管理": 7.4
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "良好",
        "items": {
          "pbPoints": 0,
          "pePoints": 0.4,
          "epsPoints": 0.75,
          "roePoints": 0,
          "debtPoints": 0.5,
          "marginPoints": 0,
          "turnoverUsdM": 584.5260885,
          "volumePoints": 0.5,
          "revenuePoints": 0.6,
          "dividendPoints": 0.3,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "較差",
        "items": {
          "cmfPoints": 0.8,
          "mfiPoints": 0.8,
          "obvPoints": 4,
          "vwapPoints": 0.8,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.MCK",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "良好",
        "items": {
          "vix": {
            "score": 2.4,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 14.21
            }
          },
          "trend": {
            "score": 4,
            "details": {
              "qqq": {
                "ma20": 718.2184960000001,
                "ma50": 711.4151976999997,
                "name": "QQQ",
                "close": 741.21002,
                "points": 2
              },
              "spy": {
                "ma20": 765.28299795,
                "ma50": 760.9057979799998,
                "name": "SPY",
                "close": 767.81,
                "points": 2
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 2.338444065871664,
          "atrPoints": 3,
          "cciPoints": 1.6,
          "vixPoints": 2.4,
          "marketTrendPoints": 4
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "較差",
        "items": {
          "sentiment": {
            "score": 4,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "negativeHits": 0,
              "positiveHits": 2,
              "sentimentScoreRaw": 0.6
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 142359800,
                "url": "https://finnhub.io/api/news?id=21e8d0e8b0fadadc3e3fa8b51bd2ad4e5bbe2da4679cc19d5fb4855b1a5b0ec9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",
                "category": "company",
                "datetime": 1790168407,
                "headline": "McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know"
              },
              {
                "id": 142315583,
                "url": "https://finnhub.io/api/news?id=eabc3a29647ff9263112fd7e84226baafd3f2b824601a72d0d96d7ab23b38c35",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Since March 2026, McKesson has been in a holding pattern, floating around $872.99. The stock also fell short of the S&P 500’s 16.4% gain during that period.",
                "category": "company",
                "datetime": 1790021665,
                "headline": "3 Reasons MCK Has Explosive Upside Potential"
              },
              {
                "id": 142200788,
                "url": "https://finnhub.io/api/news?id=a4910f7cc28036c8a64eeb8d9900dc45afbb6ca9c7658607d338bee2cac6f6c6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson (MCK) closed at $887.29 in the latest trading session, marking a -1.36% move from the prior day.",
                "category": "company",
                "datetime": 1789595404,
                "headline": "McKesson (MCK) Sees a More Significant Dip Than Broader Market: Some Facts to Know"
              },
              {
                "id": 142197211,
                "url": "https://finnhub.io/api/news?id=fa5c0c94bd0a3b0d0eb0b39a7c41bebafa4e33cde64a461c0074cfb715c4f818",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Alluvium Asset Management, an asset management company, released its “Conventum – Alluvium Global Fund” second-quarter 2026 investor letter. The letter can be downloaded here. The second quarter reflected a sharp shift from geopolitical uncertainty and oil market volatility to a powerful equity rally led by semiconductor companies. Despite the broader market strength, the Fund declined […]",
                "category": "company",
                "datetime": 1789571094,
                "headline": "Alluvium Raised Its McKesson (MCK) Stake as Long-Term Growth Expectations Remain Strong"
              },
              {
                "id": 142158577,
                "url": "https://finnhub.io/api/news?id=df523848265bf481e0a7f7ef18142b6d13d71c1fffdfc497171396fd88af6155",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson recently raised its full-year EPS guidance, projecting approximately 13%–15% growth (15%–17% excluding certain prior-year items), and outlined plans to rebrand its Medical-Surgical unit as Wellverse with a potential IPO targeted for the second half of 2027, alongside a pending acquisition of Precision Medicine Group to expand oncology and biopharma-services capabilities, subject to regulatory approval. This combination of upgraded earnings expectations, portfolio reshaping around...",
                "category": "company",
                "datetime": 1789463504,
                "headline": "Did McKesson’s (MCK) EPS Hike and Oncology Push Just Redefine Its Investment Narrative?"
              },
              {
                "id": 142138058,
                "url": "https://finnhub.io/api/news?id=4d90149136c5f41327c113354fdc5242c1583fff9332db691b343e5ab0a73218",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "MCK",
                "summary": "McKesson Corporation (MCK) Morgan Stanley 24th Annual Global Healthcare Conference September 14, 2026 7:45 AM EDTCompany ParticipantsBrian Tyler - CEO &...",
                "category": "company",
                "datetime": 1789381900,
                "headline": "McKesson Corporation (MCK) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript"
              },
              {
                "id": 142067334,
                "url": "https://finnhub.io/api/news?id=c0acbb5341553aa754e7b05905d53396d38f96fa91222d73ec5bc641c41c6ee1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson (MCK) closed at $880.86 in the latest trading session, marking a -1.21% move from the prior day.",
                "category": "company",
                "datetime": 1789077605,
                "headline": "McKesson (MCK) Suffers a Larger Drop Than the General Market: Key Insights"
              },
              {
                "id": 142024856,
                "url": "https://finnhub.io/api/news?id=fdc43e5ec4ba34605b1cb41f008eaddf49644481fa8eafdae01168b12a3c2d1e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson (MCK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",
                "category": "company",
                "datetime": 1788958804,
                "headline": "McKesson Corporation (MCK) Is a Trending Stock: Facts to Know Before Betting on It"
              }
            ],
            "raw_source": [
              {
                "id": 142359800,
                "url": "https://finnhub.io/api/news?id=21e8d0e8b0fadadc3e3fa8b51bd2ad4e5bbe2da4679cc19d5fb4855b1a5b0ec9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",
                "category": "company",
                "datetime": 1790168407,
                "headline": "McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know"
              },
              {
                "id": 142359801,
                "url": "https://finnhub.io/api/news?id=e2eeb3460907b49da59df8b243b36bf8808d025644ac999e210fc49d00082d55",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "IRVING, Texas, September 23, 2026--McKesson Corporation (NYSE: MCK) will release its second quarter fiscal 2027 financial results after market close on Wednesday, November 4, 2026. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results.",
                "category": "company",
                "datetime": 1790164800,
                "headline": "McKesson Corporation Announces Second Quarter Fiscal 2027 Earnings Release Date"
              },
              {
                "id": 142337859,
                "url": "https://finnhub.io/api/news?id=5e90da72b9445f8f269fe769a77eee231cb102829bca91c22fcabee80a02ffe0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "CAH is expanding its MSO strategy across specialty care, with Solaris and broader services aimed at scaling physician networks.",
                "category": "company",
                "datetime": 1790083920,
                "headline": "Can CAH's MSO Expansion Unlock Growth in Specialty Care Delivery?"
              },
              {
                "id": 142315583,
                "url": "https://finnhub.io/api/news?id=eabc3a29647ff9263112fd7e84226baafd3f2b824601a72d0d96d7ab23b38c35",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Since March 2026, McKesson has been in a holding pattern, floating around $872.99. The stock also fell short of the S&P 500’s 16.4% gain during that period.",
                "category": "company",
                "datetime": 1790021665,
                "headline": "3 Reasons MCK Has Explosive Upside Potential"
              },
              {
                "id": 142259528,
                "url": "https://finnhub.io/api/news?id=3a1e2000579852f3b34752bbd857d32b9504e254c87464c87d497a08838a6184",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "AbbVie's immunology franchise is firing on all cylinders while Bristol Myers Squibb navigates revenue declines and legal uncertainty.",
                "category": "company",
                "datetime": 1789738501,
                "headline": "AbbVie vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026?"
              },
              {
                "id": 142258086,
                "url": "https://finnhub.io/api/news?id=609ac00b5cd43a3cdf9674d3ec513292d7a9ffa17a752ca1e6ecd17075ce8b5f",
                "image": "https://image.cnbcfm.com/api/v1/image/108364583-17896719001789671898-48440813815-1080pnbcnews.jpg?v=1789671899&w=1920&h=1080",
                "source": "CNBC",
                "related": "MCK",
                "summary": "Skyler Weinand, Regan Capital CIO, joins 'Power Lunch' to discuss the best stocks for a sustained rate hike cycle.",
                "category": "company",
                "datetime": 1789657793,
                "headline": "Really like Northrop Grumman as a value play, says Regan Capital's Skyler Weinand"
              },
              {
                "id": 142220724,
                "url": "https://finnhub.io/api/news?id=825ed465d57b9b84b5b396a439153daf594d2d7e37c3d9353a2aed5c3fb912fd",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other business lines such as M&A advisory.",
                "category": "company",
                "datetime": 1789639817,
                "headline": "1 Unpopular Stock That Deserves Some Love and 2 We Turn Down"
              },
              {
                "id": 142200788,
                "url": "https://finnhub.io/api/news?id=a4910f7cc28036c8a64eeb8d9900dc45afbb6ca9c7658607d338bee2cac6f6c6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson (MCK) closed at $887.29 in the latest trading session, marking a -1.36% move from the prior day.",
                "category": "company",
                "datetime": 1789595404,
                "headline": "McKesson (MCK) Sees a More Significant Dip Than Broader Market: Some Facts to Know"
              },
              {
                "id": 142197211,
                "url": "https://finnhub.io/api/news?id=fa5c0c94bd0a3b0d0eb0b39a7c41bebafa4e33cde64a461c0074cfb715c4f818",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Alluvium Asset Management, an asset management company, released its “Conventum – Alluvium Global Fund” second-quarter 2026 investor letter. The letter can be downloaded here. The second quarter reflected a sharp shift from geopolitical uncertainty and oil market volatility to a powerful equity rally led by semiconductor companies. Despite the broader market strength, the Fund declined […]",
                "category": "company",
                "datetime": 1789571094,
                "headline": "Alluvium Raised Its McKesson (MCK) Stake as Long-Term Growth Expectations Remain Strong"
              },
              {
                "id": 142196161,
                "url": "https://finnhub.io/api/news?id=46d70f9b74121585ca06e5d2ef366b344e8513f300a3d9cd58c838723572a5d2",
                "image": "https://cdn.benzinga.com/files/images/story/2025/07/10/valuestock_3.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "MCK",
                "summary": "McKesson (NYSE:MCK) has outperformed the market over the past 5 years by 23.05% on an annualized basis producing an average annual return of 34.83%. Currently, McKesson has a market capitalization of $104.88 billion.",
                "category": "company",
                "datetime": 1789490740,
                "headline": "Here’s How Much You Would Have Made Owning McKesson Stock In The Last 5 Years"
              },
              {
                "id": 142158577,
                "url": "https://finnhub.io/api/news?id=df523848265bf481e0a7f7ef18142b6d13d71c1fffdfc497171396fd88af6155",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson recently raised its full-year EPS guidance, projecting approximately 13%–15% growth (15%–17% excluding certain prior-year items), and outlined plans to rebrand its Medical-Surgical unit as Wellverse with a potential IPO targeted for the second half of 2027, alongside a pending acquisition of Precision Medicine Group to expand oncology and biopharma-services capabilities, subject to regulatory approval. This combination of upgraded earnings expectations, portfolio reshaping around...",
                "category": "company",
                "datetime": 1789463504,
                "headline": "Did McKesson’s (MCK) EPS Hike and Oncology Push Just Redefine Its Investment Narrative?"
              },
              {
                "id": 142139308,
                "url": "https://finnhub.io/api/news?id=8f218e6f7b910d123201ac23fb800ce70f363d4a3dd35a78f17158dcc3292a09",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "AbbVie is profitable, growing, and paying a rising dividend. CRISPR is burning cash in pursuit of a gene-editing breakthrough that could reshape medicine.",
                "category": "company",
                "datetime": 1789398055,
                "headline": "AbbVie vs. CRISPR Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?"
              },
              {
                "id": 142137295,
                "url": "https://finnhub.io/api/news?id=dcc4b288ae6e93f54675969bd802a9ab516ad006a056529faa42c98979a51c3e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson (NYSE:MCK) executives said the company’s first-quarter performance supported a higher full-year earnings outlook, citing broad-based growth across its North American Pharmaceutical, Oncology & Multispecialty and Prescription Technology Solutions businesses. Speaking at the Morgan Stanl",
                "category": "company",
                "datetime": 1789390938,
                "headline": "McKesson Raises Outlook, Eyes Oncology Growth With Precision Medicine Deal"
              },
              {
                "id": 142135993,
                "url": "https://finnhub.io/api/news?id=da1e88d3e7f35b8059dfd20fd97ed62f63419a669479637d7a9f61c48ee2f6bc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Amgen trades at a cheaper valuation but carries higher leverage, while Vertex boasts pristine finances and 32% net margins, a classic trade-off between value and quality.",
                "category": "company",
                "datetime": 1789383825,
                "headline": "Amgen vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?"
              },
              {
                "id": 142138058,
                "url": "https://finnhub.io/api/news?id=4d90149136c5f41327c113354fdc5242c1583fff9332db691b343e5ab0a73218",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "MCK",
                "summary": "McKesson Corporation (MCK) Morgan Stanley 24th Annual Global Healthcare Conference September 14, 2026 7:45 AM EDTCompany ParticipantsBrian Tyler - CEO &...",
                "category": "company",
                "datetime": 1789381900,
                "headline": "McKesson Corporation (MCK) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript"
              },
              {
                "id": 142163085,
                "url": "https://finnhub.io/api/news?id=ed034ae5db6b4ec4061bdcecf7d571dc60aa47a4e0212d5e8b8b81b1993087e9",
                "image": "",
                "source": "Benzinga",
                "related": "MCK",
                "summary": "RBC Capital  analyst Ryan Halsted   reiterates McKesson (NYSE:MCK) with a Sector Perform and maintains $845 price target.",
                "category": "company",
                "datetime": 1789379722,
                "headline": "RBC Capital Reiterates Sector Perform on McKesson, Maintains $845 Price Target"
              },
              {
                "id": 142089518,
                "url": "https://finnhub.io/api/news?id=2b34a2a5a93661fb44b03a5ae23beb9474b495656e1ceef30023166f3e89facb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Cardinal Health's 29% rally reflects stronger specialty growth, MSO expansion and higher-margin assets, but cost pressures could test the uptrend.",
                "category": "company",
                "datetime": 1789150860,
                "headline": "CAH Gains More Than 29% in 4 Months: Will the Uptrend Continue?"
              },
              {
                "id": 142087142,
                "url": "https://finnhub.io/api/news?id=d6d0c72b86d9e618670b0425256ff71064320995e71838714d702775481e1376",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Amgen is profitable and paying a growing dividend, while Revolution Medicines is burning cash to fund what could be one of the most important cancer drug launches in years.",
                "category": "company",
                "datetime": 1789141777,
                "headline": "Amgen vs. Revolution Medicines: Which Healthcare Stock Is a Better Buy in 2026?"
              },
              {
                "id": 142087143,
                "url": "https://finnhub.io/api/news?id=76d994f26a70f0f9c15f617bc2f51be0a2aaee74fdcd41e930440fc7f064cf70",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "One company is generating billions in revenue and raising its dividend. The other is burning cash in pursuit of a scientific breakthrough that could change how diseases are treated.",
                "category": "company",
                "datetime": 1789140567,
                "headline": "Amgen vs. CRISPR Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?"
              },
              {
                "id": 142067334,
                "url": "https://finnhub.io/api/news?id=c0acbb5341553aa754e7b05905d53396d38f96fa91222d73ec5bc641c41c6ee1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson (MCK) closed at $880.86 in the latest trading session, marking a -1.21% move from the prior day.",
                "category": "company",
                "datetime": 1789077605,
                "headline": "McKesson (MCK) Suffers a Larger Drop Than the General Market: Key Insights"
              },
              {
                "id": 142063302,
                "url": "https://finnhub.io/api/news?id=ad181144a7d06182ba609e0908d03dc6ded85f4ed97764dbd7f7ce1ac0017980",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "AbbVie's diversified portfolio faces patent headwinds, while Novo Nordisk dominates a faster-growing market, but one trades at a steeper valuation.",
                "category": "company",
                "datetime": 1789062373,
                "headline": "AbbVie vs. Novo Nordisk: Which Healthcare Stock Is a Better Buy in 2026?"
              },
              {
                "id": 142063354,
                "url": "https://finnhub.io/api/news?id=048a492322933b269d7e80caf13a16d0fcc27cc8948d27855f206759fbc84081",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Amgen trades at a fraction of Moderna's valuation, but one company is burning cash while the other generates billions, a critical divide for income-focused investors.",
                "category": "company",
                "datetime": 1789057284,
                "headline": "Amgen vs. Moderna: Which Healthcare Stock Is a Better Buy in 2026?"
              },
              {
                "id": 142062044,
                "url": "https://finnhub.io/api/news?id=560137700fdb0274b2b3959c029fe5878e28a09596be394126c5f9b6d5d4d425",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Cardinal (CAH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
                "category": "company",
                "datetime": 1789054203,
                "headline": "Cardinal (CAH) Up 2.5% Since Last Earnings Report: Can It Continue?"
              },
              {
                "id": 142056230,
                "url": "https://finnhub.io/api/news?id=89cb57547d412435307bb9f21f5d4dfe69480622ee86b74a472f5db60470e660",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1309251202/image_1309251202.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "MCK",
                "summary": "The largest positive contributors included Seagate, Micron, and Taiwan Semiconductor. Read more here.",
                "category": "company",
                "datetime": 1789021800,
                "headline": "Janus Henderson Global Sustainable Equity (ADR) Managed Account Q2 2026 Portfolio Update"
              },
              {
                "id": 142024856,
                "url": "https://finnhub.io/api/news?id=fdc43e5ec4ba34605b1cb41f008eaddf49644481fa8eafdae01168b12a3c2d1e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson (MCK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",
                "category": "company",
                "datetime": 1788958804,
                "headline": "McKesson Corporation (MCK) Is a Trending Stock: Facts to Know Before Betting on It"
              },
              {
                "id": 142024857,
                "url": "https://finnhub.io/api/news?id=24b6718bedd1e62e047e22a7dd80db0667efcdb5adbe49ba4fa336e63fe9f492",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "SEATTLE, September 09, 2026--Frazier Healthcare Partners, a private equity firm focused exclusively on the healthcare industry, is pleased to announce that Tom Rodgers will join the firm as a Senior Partner in October 2026. In this role, Mr. Rodgers will partner with Frazier’s Growth Buyout deal teams, providing strategic counsel on investment evaluation, portfolio value creation, and sector-level insights informed by more than 35 years of experience in healthcare strategy, corporate development",
                "category": "company",
                "datetime": 1788955200,
                "headline": "Frazier Healthcare Partners Welcomes Tom Rodgers as Senior Partner"
              },
              {
                "id": 141952689,
                "url": "https://finnhub.io/api/news?id=b4df56d6015169489daf46666a01566f77be8ab57d8d5bfde1d18d2e1638dc87",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "The best-performing stocks typically have robust sales growth, increasing margins, and rising returns on capital, and those that can maintain this trifecta year in and year out often become the legends of the investing world.",
                "category": "company",
                "datetime": 1788886998,
                "headline": "3 Market-Beating Stocks for Long-Term Investors"
              },
              {
                "id": 141950716,
                "url": "https://finnhub.io/api/news?id=8483fa41d6072ee44cea77dcbda0a547cebf1d856a602d91d28e799874c7640c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson (NYSE:MCK) discussed its planned $2.25 billion acquisition of Precision Medicine Group, first-quarter operating trends and capital-allocation priorities during a presentation with Wells Fargo analyst Stephen Baxter. The company said Precision Medicine Group would expand two areas it has id",
                "category": "company",
                "datetime": 1788872528,
                "headline": "McKesson Eyes $2.25B Precision Medicine Deal as Oncology Growth Accelerates"
              },
              {
                "id": 141950717,
                "url": "https://finnhub.io/api/news?id=849bf6844aa6949a68d02d3ef7ff13a7c0b6166e85f0e4c74feecce7b70a04b0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "CHICAGO, September 08, 2026--Shore Capital Partners (\"Shore\" or \"Shore Capital\"), a Chicago-based private equity firm with an office in Nashville, today announced that Tommy Pourmahram has been named Chief Executive Officer of Reliant Infusion, a Shore portfolio company and provider of specialty infusion services.",
                "category": "company",
                "datetime": 1788872400,
                "headline": "Reliant Infusion Names Tommy Pourmahram Chief Executive Officer"
              },
              {
                "id": 141949426,
                "url": "https://finnhub.io/api/news?id=a31af409867bcaa71974fe4e8d7bf4b7e6c90421c76a5629c04f971119f24b07",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "MCK",
                "summary": "McKesson Corporation (MCK) Wells Fargo 21st Annual Healthcare Conference September 8, 2026 8:00 AM EDTCompany ParticipantsKenny Cheung - Executive VP &...",
                "category": "company",
                "datetime": 1788864352,
                "headline": "McKesson Corporation (MCK) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript"
              },
              {
                "id": 141808253,
                "url": "https://finnhub.io/api/news?id=83dffed7de3f2b65ec0363da9b401d307f735e8a5b9dc4236e3023551fd7192c",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/942145090/image_942145090.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "MCK",
                "summary": "McKesson operates within a US pharma distribution oligopoly, generating $5B+ in FCF and aggressively repurchasing shares. See why I rate MCK stock a Buy.",
                "category": "company",
                "datetime": 1788833333,
                "headline": "Underestimating The Moat: Why McKesson's Oncology Pivot And Share Buybacks Signal Structural Upside"
              },
              {
                "id": 141765194,
                "url": "https://finnhub.io/api/news?id=6aa53833c6e108cbd1eac942a34ce50a40cb1ebda0d60db67ea6cdcd204a6962",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "CVS Health is advancing Aetna's profitability turnaround, supported by stronger Health Care Benefits results, an improved MBR and operational initiatives.",
                "category": "company",
                "datetime": 1788796200,
                "headline": "Here's How CVS Is Focusing on Aetna's Profitability Turnaround"
              },
              {
                "id": 141593755,
                "url": "https://finnhub.io/api/news?id=86f8969ab47c49412072028654335b4ce82e4065a7327a97008c027d9ebdde4c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Reuters reported that McKesson Corporation (NYSE:MCK) said it would buy privately held Precision Medicine Group in a deal valued at about $2.25 billion as part of a “years-long effort to strengthen its higher-growth businesses.” McKesson has been reshaping its portfolio by exiting non-core assets and streamlining its operations while investing in businesses such as oncology […]",
                "category": "company",
                "datetime": 1788731019,
                "headline": "McKesson Bets $2.25 Billion More on Oncology With Precision Medicine Buy"
              },
              {
                "id": 141455037,
                "url": "https://finnhub.io/api/news?id=882e78db4092ee8e4a4f8c9153c570608198427b13f54f3413147816ac706bb2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "AbbVie's immunology pivot is offsetting Humira's decline, while Pfizer trades at half the valuation despite patent risks ahead.",
                "category": "company",
                "datetime": 1788547801,
                "headline": "AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?"
              },
              {
                "id": 141437664,
                "url": "https://finnhub.io/api/news?id=3357c2f285bd11902a992ee033011f12209873b2e3e36a0b5a1c42f5be967018",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson (MCK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
                "category": "company",
                "datetime": 1788535831,
                "headline": "Why Is McKesson (MCK) Up 5.7% Since Last Earnings Report?"
              },
              {
                "id": 141455245,
                "url": "https://finnhub.io/api/news?id=dd156e46da0fd830ecf192501040ce786d5f1158745241229cfb61def8709aa7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson has outpaced the healthcare sector, and analysts remain highly optimistic about the stock’s outlook.",
                "category": "company",
                "datetime": 1788525784,
                "headline": "McKesson Stock: Is MCK Outperforming the Healthcare Sector?"
              },
              {
                "id": 141446166,
                "url": "https://finnhub.io/api/news?id=2c89c2975d89a1f9f49ebd0e30276c2f76bd6a4d77b88da08d663e5f5ac92c62",
                "image": "https://cdn.benzinga.com/files/images/story/2025/11/06/insider_trade_3.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "MCK",
                "summary": "A September filing shows that Representative Jonathan Jackson reported a sale in Viasat (NASDAQ:VSAT), valued between $1,001 and $15,000. The transaction date is listed as August 28, 2026, with the report published on",
                "category": "company",
                "datetime": 1788519613,
                "headline": "A Congress Member Sold Up To $15K In Viasat Stock: Here's What You Need To Know"
              },
              {
                "id": 141406350,
                "url": "https://finnhub.io/api/news?id=7f06d643160898f1cbdc391a8a9105109c98cd0a5edf1bf978d1a4c97a7e8a62",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "On the September 2 episode of Mad Money, Jim Cramer called Cardinal Health, Inc. (NYSE:CAH) one of his “absolute favorites” and mentioned its growing exposure to specialty pharmaceuticals and higher-margin healthcare services. Cardinal’s been running circles around McKesson and Cencora. They consistently put up the best numbers because this company has gradually become less of […]",
                "category": "company",
                "datetime": 1788472375,
                "headline": "Jim Cramer Notes Cardinal Health (CAH) is “Too Attractive to Ignore”"
              },
              {
                "id": 141403880,
                "url": "https://finnhub.io/api/news?id=2e84096df15ac30b56cad9794a7c930f96ca0a6d437a48ac470b179160eb83fb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Cencora raised its fiscal 2026 EPS outlook as specialty businesses fueled stronger profit growth despite mix, pricing and financing pressures.",
                "category": "company",
                "datetime": 1788463320,
                "headline": "Cencora Raises 2026 EPS Outlook as Specialty Businesses Strengthen"
              },
              {
                "id": 141398251,
                "url": "https://finnhub.io/api/news?id=328a82c3d457909e88b69b893d71448dd5d5c025b99eb4233343050a4eaa9df2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Cardinal Health's generic volumes, profitable brand-to-generic conversions and Red Oak program continue to support Pharma profits.",
                "category": "company",
                "datetime": 1788441720,
                "headline": "Is Generics Still a Quiet Profit Engine for Cardinal Health?"
              },
              {
                "id": 141379924,
                "url": "https://finnhub.io/api/news?id=6afcece2c335857767d8a7dc325db935366d73038876930ff1f2cb2b051c6760",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "The healthcare distributor said the incident affected a subset of customers in its oncology and medical-surgical businesses.",
                "category": "company",
                "datetime": 1788349876,
                "headline": "McKesson confirms data theft in cyberattack involving third-party apps"
              },
              {
                "id": 141362499,
                "url": "https://finnhub.io/api/news?id=5c7d450744a64abf76b03d01f59feaa6a0193540e5b8b10958925600f68cc7eb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.",
                "category": "company",
                "datetime": 1788269402,
                "headline": "Here's How Much a $1000 Investment in McKesson Made 10 Years Ago Would Be Worth Today"
              },
              {
                "id": 141348564,
                "url": "https://finnhub.io/api/news?id=7009d4f82a8712cebfa86427db9a724d72e0b2b5febcd81764d5d26f56545d3b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "AbbVie trades cheaper but carries heavy revenue concentration; Johnson & Johnson boasts a fortress balance sheet and wider portfolio.",
                "category": "company",
                "datetime": 1788028861,
                "headline": "AbbVie vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?"
              },
              {
                "id": 141361438,
                "url": "https://finnhub.io/api/news?id=940a43f5ddc818d2bd608a743ecdb586ed6fb5e91ade75734e7d1edb77b505aa",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Amgen generated $8.1 billion in free cash flow in 2025, with a 21% net margin, while Axsome is scaling rapidly but still unprofitable.",
                "category": "company",
                "datetime": 1788023101,
                "headline": "Amgen vs. Axsome Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?"
              },
              {
                "id": 141362484,
                "url": "https://finnhub.io/api/news?id=42a808ca6565b338678350b3fd37bbec66952747baaad7bca11942fce2cc3284",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson Corporation (NYSE:MCK) has agreed to acquire privately held Precision Medicine Group for approximately $2.25 billion, as the healthcare company continues shifting its portfolio toward higher-growth businesses. Precision Medicine provides clinical research, laboratory testing, and commercialization services to biotechnology and pharmaceutical companies developing and launching new medicines. McKesson plans to integrate the company into its […]",
                "category": "company",
                "datetime": 1787977965,
                "headline": "McKesson Corporation (MCK) Doubles Down on Healthcare Growth With Precision Medicine Acquisition"
              },
              {
                "id": 141341224,
                "url": "https://finnhub.io/api/news?id=a70f356816315e6c1cffbf3ddb6582552dedd39464f32f29f67f627611d5c738",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "MCK",
                "summary": "Dividend activity recap for Champions, Contenders & Challengers: dividend changes plus upcoming ex-dividend and pay dates. See more here.",
                "category": "company",
                "datetime": 1787954658,
                "headline": "Dividend Champion, Contender, And Challenger Highlights: Week August 30"
              },
              {
                "id": 141345937,
                "url": "https://finnhub.io/api/news?id=9aa1b0e18be5e6d174f41bbc3dc796dcb4158949f0235d825fd43014622745c4",
                "image": "",
                "source": "Benzinga",
                "related": "MCK",
                "summary": "https://www.sec.gov/ix?doc=/Archives/edgar/data/0000927653/000092765326000247/mck-20260825.htm",
                "category": "company",
                "datetime": 1787933458,
                "headline": "McKesson Says It Discovered Cybersecurity Incident Affecting Its Information Systems On August 25; Investigation In Early Stages, Has Not Determined If Incident Is Material"
              },
              {
                "id": 141362485,
                "url": "https://finnhub.io/api/news?id=e47f723e4ec811f4f889f00701e1a45f0651849549dc22c3af7995545000aa1f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson (NYSE:MCK) announced an agreement to acquire Precision Medicine Group to expand its oncology and clinical research services. The deal is aimed at deepening McKesson's role in personalized medicine and specialty care, particularly in oncology and biopharma clinical trial support. The acquisition is expected to reshape McKesson's service mix across oncology practices, biopharma partners and clinical research organizations. For readers looking beyond McKesson to other potential...",
                "category": "company",
                "datetime": 1787865406,
                "headline": "What Does McKesson (MCK) Gain From Its Push Into Oncology And Clinical Research?"
              },
              {
                "id": 141362486,
                "url": "https://finnhub.io/api/news?id=1f989b9642ae7bee3a901cd1882915a8ee1c8ac1bcde15bfe832a682f244e6fe",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "DENVER, August 27, 2026--Modivcare, a leading provider of non-emergency transportation, personal care services, and monitoring solutions, announced the appointment of Matt Williams as Chief Corporate Affairs Officer, effective September 1, 2026.",
                "category": "company",
                "datetime": 1787859240,
                "headline": "Modivcare Appoints Matt Williams as Chief Corporate Affairs Officer"
              },
              {
                "id": 141338176,
                "url": "https://finnhub.io/api/news?id=87625a941bafa88d74ed14c99a4be44d2e38601a7bb34d9b743e2794daa4a3fa",
                "image": "https://cdn.benzinga.com/files/images/story/2025/07/10/valuestock_1.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "MCK",
                "summary": "McKesson (NYSE:MCK) has outperformed the market over the past 10 years by 3.54% on an annualized basis producing an average annual return of 17.04%. Currently, McKesson has a market capitalization of $103.82 billion.",
                "category": "company",
                "datetime": 1787850935,
                "headline": "Here’s How Much You Would Have Made Owning McKesson Stock In The Last 10 Years"
              },
              {
                "id": 141362487,
                "url": "https://finnhub.io/api/news?id=859e66a15a81fed71b31f1f47807c408b556a8a74534b8edfe4ea2da17ed01a0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "MCK's $2.25B Precision Medicine Group deal aims to expand clinical research and commercialization services in oncology and multispecialty care.",
                "category": "company",
                "datetime": 1787847720,
                "headline": "McKesson to Acquire Precision Medicine Group to Strengthen Services"
              },
              {
                "id": 141362498,
                "url": "https://finnhub.io/api/news?id=11d84ed8bc0e1b31e4fee811e4457043fb9729476054630b1fcc47aa72df7e8b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "A real-world study suggests Zepbound use could reduce the rates of hospital stays and ER visits. Elsewhere, McKesson sprung for a multibillion-dollar deal and J&J nabbed a noteworthy approval.",
                "category": "company",
                "datetime": 1787742695,
                "headline": "Zepbound may cut healthcare costs, study says; Summit, Akeso drug hits in another China trial"
              },
              {
                "id": 141362488,
                "url": "https://finnhub.io/api/news?id=db0403d82390c00d8bcdfd1c1a92e2a7f3c4b8870698d860d52cf130d97c3259",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson believes that the deal will support its clinical research and biopharmaceutical commercialisation services.",
                "category": "company",
                "datetime": 1787741174,
                "headline": "McKesson to acquire Precision Medicine Group for $2.25bn"
              },
              {
                "id": 141362489,
                "url": "https://finnhub.io/api/news?id=8fea69045a18763479a2d565ca9a79326b7d37506435edfef369512728d3186a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Healthcare stocks rose late Tuesday afternoon with the NYSE Healthcare Index and the State Street He",
                "category": "company",
                "datetime": 1787691435,
                "headline": "Sector Update: Healthcare Stocks Advance Late Afternoon"
              },
              {
                "id": 141362490,
                "url": "https://finnhub.io/api/news?id=61f1e295314b78b284effd3ecf0f2a180194ab0bb8668aa49d6383a463f2b73c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "The drug distributor will fold the clinical research and biopharma commercialization firm into its oncology unit once the deal closes",
                "category": "company",
                "datetime": 1787683713,
                "headline": "McKesson to acquire Precision Medicine Group for $2.25 billion"
              },
              {
                "id": 141362500,
                "url": "https://finnhub.io/api/news?id=c97396ca69cebd061cfc6360bafae78a6e230404b8a15b7da204581678be53e6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "MCK's specialty distribution, oncology and technology businesses are fueling growth, while drug-pricing pressure and policy shifts pose risks.",
                "category": "company",
                "datetime": 1787677260,
                "headline": "Here's Why You Should Retain McKesson Stock in Your Portfolio for Now"
              },
              {
                "id": 141362491,
                "url": "https://finnhub.io/api/news?id=d01bee3895bd2a8a8fc9cfa10de581da43b7ddb7ca5b61497c518cc26acfb2e8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson (MCK) has agreed to acquire Precision Medicine in a transaction worth roughly $2.25 billion",
                "category": "company",
                "datetime": 1787676455,
                "headline": "McKesson to Buy Precision Medicine in $2.25 Billion Deal"
              },
              {
                "id": 141362492,
                "url": "https://finnhub.io/api/news?id=41c37e829247116594950d3dff826f9f47e0a213a986e3946b0f02205ba92f60",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson Corporation (NYSE:MCK) on Tuesday announced an agreement to acquire Precision Medicine Group.The deal provides McKesson with an opportunity to expand its clinical research and commercialization services.McKesson will acquire Precision Medicine Group for approximately $2.25 billion.Following completion of the transaction, Precision Medicine Group will report within McKesson’s Oncology & Multispecialty segment, its second-largest segment with first-quarter sales of $14.2 billion.McKesson",
                "category": "company",
                "datetime": 1787675476,
                "headline": "McKesson Buys Precision Medicine to Expand Clinical Research and Commercialization"
              },
              {
                "id": 141362501,
                "url": "https://finnhub.io/api/news?id=d03ba15a1e976178b96d4c3b5e2f8f16838c6e7ed3212d968bc5a3a7a88eebc2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "IRVING, Texas, August 25, 2026--McKesson Corporation (NYSE: MCK) announced today that it signed a definitive agreement to acquire Precision Medicine Group, LLC (\"Precision Medicine Group\"), a global provider of clinical research and biopharma commercialization services.",
                "category": "company",
                "datetime": 1787662800,
                "headline": "McKesson Signs Agreement to Acquire Precision Medicine Group, LLC"
              },
              {
                "id": 141362494,
                "url": "https://finnhub.io/api/news?id=813bbe30273839d5c9e39751e4840e5380adf79983ce68785f5bc9d92a450f8a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson raises fiscal 2027 EPS guidance as oncology, GLP-1 volumes and specialty distribution drive faster profit growth despite cash-flow pressure.",
                "category": "company",
                "datetime": 1787600940,
                "headline": "McKesson Raises FY27 Guidance as Oncology and GLP-1 Growth Accelerate"
              },
              {
                "id": 141362493,
                "url": "https://finnhub.io/api/news?id=a26caf7ebd42adc41c28417195d15ca548d9f7918e53a2033fe7bbaeb5ef1826",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson's double-digit earnings growth, specialty expansion and capital returns support the story, but a premium valuation leaves less room for error.",
                "category": "company",
                "datetime": 1787600940,
                "headline": "Is McKesson Stock Worth Buying as Growth Meets a Premium Valuation?"
              },
              {
                "id": 141362495,
                "url": "https://finnhub.io/api/news?id=249f65582612259e488427d63d20ac05971ace8e805a5df53806a2ad89edea44",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson has outperformed the broader market over the past year, and analysts are highly optimistic about the stock’s prospects.",
                "category": "company",
                "datetime": 1787585960,
                "headline": "McKesson Stock Outlook: Is Wall Street Bullish or Bearish?"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 8,
            "negative_hits": 0,
            "positive_hits": 2,
            "recomputed_at_score": true,
            "sentiment_score_raw": 0.6,
            "source_article_count": 62,
            "discarded_article_count": 49
          },
          "sentimentPoints": 4
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 16.9,
        "grade": "較差",
        "items": {
          "bbPoints": 2.4,
          "adxPoints": 3,
          "sarPoints": 1.2000000000000002,
          "vcpPoints": 2.2,
          "macdPoints": 2.4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 2.2,
            "vcp_reason": "波幅收縮(10.5%→5.4%)；跌縮量(近10日3日)；站上MA50；Ready=Y；Confirm=N",
            "vcp_metrics": {
              "up_days": 4,
              "vol_ref": 951023.5,
              "down_days": 5,
              "vcp_ready": true,
              "above_ma50": true,
              "avg_vol_10": 1046370.5,
              "avg_vol_20": 979490.25,
              "avg_vol_30": 951023.5,
              "range_pct_10": 0.054378194207836454,
              "range_pct_20": 0.07476434980124931,
              "range_pct_30": 0.10456559909142535,
              "up_expand_ok": false,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": true,
              "down_shrink_ok": true,
              "up_expand_days": 0,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 1.1002572491636642,
              "dist_to_20d_high": 0.05317491205790731,
              "down_shrink_days": 3,
              "breakout_level_20d": 929.95001,
              "vcp_breakout_confirm": false,
              "contraction_ratio_10_30": 0.520039044201255
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": true
          },
          "kdjAdxPoints": 0.7,
          "rsiKdjPoints": 1.6,
          "volumeWeight": 2,
          "maCrossPoints": 1.6,
          "shortRsiPoints": 0,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 1,
          "volumePointsTechnical": 0.4
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "良好",
        "items": {
          "position": {
            "score": 1.6,
            "details": {
              "atrPct": 2.338444065871664,
              "turnoverUsdM": 584.5260885,
              "liquidityPoints": 0.6,
              "volatilityPoints": 1
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.MCK",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 839.32,
            "strength_details": {
              "ma_score": 1.5,
              "atr_score": 2,
              "rsi_score": 2.5,
              "macd_score": 1.5,
              "volume_score": 1
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1.1,
            "stop_loss_percent": 4.7,
            "take_profit_price": 924.525,
            "target_multiplier": 1.9,
            "technical_strength": 1.68,
            "take_profit_percent": 5
          },
          "positionPoints": 1.6,
          "stopLossPoints": 2.4,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 4.676888131743328,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 85.71,
    "atr": {
      "atr": 20.59,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 6,
      "atr_pct": 2.34
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "弱勢",
      "score": 4,
      "value": -34.77
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "派發",
      "score": 2,
      "value": -0.0291
    },
    "kdj": {
      "d": 36.43,
      "j": 42.73,
      "k": 38.53,
      "rule": "Cursor_18.24 K/D cross",
      "score": 4,
      "signal": "金叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "超賣或超買風險",
      "score": 2,
      "value": 24.06
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 10,
      "trend": "強流入",
      "value": -4354252,
      "recentSlope": -269935.2,
      "previousSlope": -256450
    },
    "rsi": 34.49,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 4,
      "trend": "下降",
      "value": 917.6325,
      "position": "SAR喺價上",
      "distancePct": 4.22,
      "previousTrend": "下降"
    },
    "ma50": 871.4004,
    "macd": {
      "macd": 4.076261701966018,
      "trend": "中性偏多",
      "signal": 7.72705988835299,
      "histogram": -3.6507981863869716
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 2,
      "value": 892.2893,
      "position": "<VWAP",
      "consecutiveAbove": 0
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "空升",
      "ratio": 0.69,
      "score": 2,
      "avgVolume": 968553,
      "currentVolume": 663857
    },
    "derived": {
      "ma20": 894.009,
      "ma50": 871.4004,
      "prevClose": 891.23,
      "avgVolume10": 1015516,
      "avgVolume20": 968553,
      "changePercent": -1.2,
      "avgVolumeForScore": 968553
    },
    "ma_cross": {
      "ma20": 894.009,
      "ma50": 871.4004,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "多頭",
      "score": 4,
      "prevMa20": 895.2385,
      "prevMa50": 869.8578,
      "spreadPct": 2.59,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 866.8018,
      "upper": 921.2162,
      "position": "中間"
    },
    "rsi_short": 31.75,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 0.69
    }
  }
}

{
  "close": 880.5,
  "volume": 663857,
  "changePercent": -1.2
}